|
|
.
See Category: Neoplasms
See Header: Secondary malignant neoplasm of and unsp digestive organs
ICD-10 (CM) Code and Descriptor
|
C78.89 |
Secondary malignant neoplasm of other digestive organs
|
C7889 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 10.72%
|
20.42%
|
21.26%
|
16.75%
|
11.67%
|
6.73%
|
4.18%
|
3.14%
|
1.96%
|
1.39%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C78.89*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,123
|
1,126
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,064
|
1,065
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
962
|
966
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
703
|
711
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
393
|
41,521
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
332
|
12,195
|
|
83735
|
ASSAY OF MAGNESIUM |
325
|
328
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
321
|
321
|
|
71260
|
CT THORAX DX C+ |
310
|
310
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
296
|
1,155
|
|
96413
|
CHEMO IV INFUSION 1 HR |
293
|
293
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
290
|
479
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
274
|
340
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
242
|
408
|
|
84443
|
ASSAY THYROID STIM HORMONE |
237
|
237
|
|
J2405
|
ONDANSETRON HCL INJECTION |
201
|
1,067
|
|
84100
|
ASSAY OF PHOSPHORUS |
199
|
200
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
198
|
198
|
|
J3010
|
FENTANYL CITRATE INJECTION |
197
|
299
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
192
|
2,138
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C78.89 related to the following DRG Codes:
374-376
|
